CDT EQUITY INC. Adjustments to Additional Paid in Capital, Warrant Issued
CDT EQUITY INC. (CDT) reported Adjustments to Additional Paid in Capital, Warrant Issued of $114.38 million for the 6-month period ending 2026-06-30, per its S-1 filed 2026-09-08.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-09-08
- CDT EQUITY INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2026-06-30 was $0.00.
- CDT EQUITY INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2026-03-31 was $114.38M.
- CDT EQUITY INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-12-31 was $0.00.
- CDT EQUITY INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-09-30 was $0.00.
- CDT EQUITY INC. adjustments to additional paid in capital, warrant issued for fiscal 2022 was $21.92M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: S-1 6 month − 10-Q 3 month · filed 2026-09-08 | $114.38M S-1 · filed 2026-09-08 | ||
| 2026-03-31 | $114.38M 10-Q · filed 2026-07-15 | |||
| 2024-12-31 | $0.00 derived: S-1 12 month − 10-Q 9 month · filed 2026-09-08 | $0.00 derived: sum of 2 quarters · filed 2026-09-08 | $2.39M derived: sum of 3 quarters · filed 2026-09-08 | $2.89M S-1 · filed 2026-09-08 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $2.39M derived: sum of 2 quarters · filed 2025-11-13 | $2.89M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $2.39M 10-Q · filed 2025-08-14 | $2.89M 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $502.00K 10-Q/A · filed 2025-08-14 | |||
| 2022-12-31 | $21.92M 10-K · filed 2023-03-28 | |||
| 2022-03-31 | $21.92M 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |